Investigation of polyomaviruses replication in pediatric patients with nephropathy receiving rituximab.

Abstract

Rituximab is a chimeric monoclonal antibody reacting with the CD20 antigen on B cells. It has been proposed as treatment for the idiopathic nephrotic syndrome, recurrent idiopathic nephropathy, and focal segmental glomerulosclerosis refractory to steroids. Rituximab influences T-cell immunity and may predispose the patients to opportunistic infections, such… (More)
DOI: 10.1002/jmv.23339

Topics

Cite this paper

@article{Delbue2012InvestigationOP, title={Investigation of polyomaviruses replication in pediatric patients with nephropathy receiving rituximab.}, author={Serena Delbue and Mariano Ferraresso and Francesca Elia and Mirco Belingheri and Camilla Carloni and Lucia Signorini and Silvia Carluccio and Simone Dallari and Luciana Ghio and Pasquale Ferrante}, journal={Journal of medical virology}, year={2012}, volume={84 9}, pages={1464-70} }